NO823939L - Fremgangsmaate for fremstilling av benzopyranon-derivater - Google Patents

Fremgangsmaate for fremstilling av benzopyranon-derivater

Info

Publication number
NO823939L
NO823939L NO823939A NO823939A NO823939L NO 823939 L NO823939 L NO 823939L NO 823939 A NO823939 A NO 823939A NO 823939 A NO823939 A NO 823939A NO 823939 L NO823939 L NO 823939L
Authority
NO
Norway
Prior art keywords
benzopyranon
derivatives
preparing
procedure
preparing benzopyranon
Prior art date
Application number
NO823939A
Other languages
English (en)
Other versions
NO162463B (no
NO162463C (no
Inventor
Philippe Briet
Jean-Jacques Berthelon
Francois Collonges
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of NO823939L publication Critical patent/NO823939L/no
Publication of NO162463B publication Critical patent/NO162463B/no
Publication of NO162463C publication Critical patent/NO162463C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO823939A 1981-11-25 1982-11-24 Mellomprodukter for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)-eddiksyre. NO162463C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8122019A FR2516921A1 (fr) 1981-11-25 1981-11-25 Haloalkyl-8-4h-(1) benzopyran-4-ones, et procedes de preparation

Publications (3)

Publication Number Publication Date
NO823939L true NO823939L (no) 1983-05-26
NO162463B NO162463B (no) 1989-09-25
NO162463C NO162463C (no) 1990-01-10

Family

ID=9264330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823939A NO162463C (no) 1981-11-25 1982-11-24 Mellomprodukter for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)-eddiksyre.

Country Status (24)

Country Link
EP (1) EP0080419B1 (no)
JP (1) JPS5896038A (no)
AR (1) AR243249A1 (no)
AT (1) ATE49760T1 (no)
AU (1) AU563066B2 (no)
CA (1) CA1197511A (no)
CS (1) CS236696B2 (no)
DD (1) DD204920A5 (no)
DE (1) DE3280092D1 (no)
DK (1) DK166778B1 (no)
ES (1) ES8308322A1 (no)
FR (1) FR2516921A1 (no)
HU (1) HU194549B (no)
IE (1) IE56916B1 (no)
IL (1) IL67290A0 (no)
IN (1) IN158942B (no)
MA (1) MA19649A1 (no)
NO (1) NO162463C (no)
NZ (1) NZ202595A (no)
OA (1) OA07256A (no)
PT (2) PT75885A (no)
SU (2) SU1189344A3 (no)
YU (1) YU43808B (no)
ZA (1) ZA828435B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002603A (en) * 1989-12-04 1991-03-26 Board Of Trustees Operating Michigan State University Method and compositions for stimulating vesicular-arbuscular mycorrhizal fungi
WO1998027080A1 (en) * 1996-12-19 1998-06-25 Agrevo Uk Limited Chromones useful as fungicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1270567B (de) * 1961-05-19 1968-06-20 Klinge Co Chem Pharm Fab Verfahren zur Herstellung von basisch substituierten Flavonen
HU168753B (no) * 1974-05-03 1976-07-28
FR2326919A2 (fr) * 1975-10-10 1977-05-06 Lipha Nouveaux acides inferieurs substitues par un radical chromonyle, leurs derives et leurs applications
FR2291745A1 (fr) * 1974-11-20 1976-06-18 Lipha Nouveaux acides inferieurs substitues par un radical chromonyl, leurs derives et leurs applications
US3966770A (en) * 1975-03-25 1976-06-29 Smithkline Corporation 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
FR2392018A1 (fr) * 1977-05-27 1978-12-22 Seuref Ag Derives de la 2,3-diphenyl-chromone, leur procede de preparation et leur application therapeutique
FR2517142A1 (fr) * 1981-11-20 1983-05-27 Efcis Bascule bistable a stockage non volatil et a repositionnement statique

Also Published As

Publication number Publication date
AU9072882A (en) 1983-06-02
FR2516921A1 (fr) 1983-05-27
IL67290A0 (en) 1983-03-31
PT75885A (fr) 1982-12-01
EP0080419B1 (fr) 1990-01-24
SU1232146A3 (ru) 1986-05-15
HU194549B (en) 1988-02-29
MA19649A1 (fr) 1983-07-01
EP0080419A3 (en) 1983-10-12
AU563066B2 (en) 1987-06-25
PT75886A (fr) 1982-12-01
DK522982A (da) 1983-05-26
FR2516921B1 (no) 1984-02-10
JPS5896038A (ja) 1983-06-07
CA1197511A (fr) 1985-12-03
DE3280092D1 (de) 1990-03-01
IE56916B1 (en) 1992-01-29
IE822753L (en) 1983-05-25
DK166778B1 (da) 1993-07-12
NO162463B (no) 1989-09-25
YU264882A (en) 1984-12-31
NO162463C (no) 1990-01-10
NZ202595A (en) 1986-02-21
ZA828435B (en) 1983-09-28
OA07256A (fr) 1984-04-30
ES517636A0 (es) 1983-08-16
ATE49760T1 (de) 1990-02-15
CS236696B2 (en) 1985-05-15
AR243249A1 (es) 1993-07-30
SU1189344A3 (ru) 1985-10-30
YU43808B (en) 1989-12-31
ES8308322A1 (es) 1983-08-16
IN158942B (no) 1987-02-21
JPH0411545B2 (no) 1992-02-28
EP0080419A2 (fr) 1983-06-01
DD204920A5 (de) 1983-12-14

Similar Documents

Publication Publication Date Title
NO822216L (no) Fremgangsmaate for fremstilling av bromhexin-retardform
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO851921L (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifanycin-derivater.
ES526827A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO822510L (no) Fremgangsmaate til fremstilling av pyridazinderivater
NO813442L (no) Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
NO820959L (no) Fremgangsmaate til fremstilling av acyl-kinolinonderivater
NO823637L (no) Fremgangsmaate for fremstilling av eburnamoninderivater
FI822464L (fi) Benzotiazolsulfonamidderivat foer lokal behandling av oekat intraokulaert tryck
NO820980L (no) Fremgangsmaate for fremstilling av imidazo-pyrimidin-derivater
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO845016L (no) Fremgangsmaate ved fremstilling av substituerte spiropyridinderivater
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.
NO810461L (no) Fremgansmaate for fremstilling av benzyliden-derivater
NO844466L (no) Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater
ES521598A0 (es) Procedimiento de preparar derivados piridotienopiridacinicos.
NO820979L (no) Fremgangsmaate for fremstilling av pyridinderivater
FI821272A0 (fi) Foerfarande foer beredning av avfallspapper